Sugammadex Sandoz 200 mg/2 ml

Sugammadex Sandoz 200 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 69439. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 May 2024 and the authorisation is limited until 30 April 2029. ATC code V03AB35 places the medicine in the group All other therapeutic products.

  • Dispensing category B
  • Authorisation number 69439
  • ATC V03AB35
  • Synthetic medicines
Authorisation data
Authorisation number69439
NameSugammadex Sandoz 200 mg/2 ml
Full nameSugammadex Sandoz 200 mg/2 ml, Injektionslösung
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeV03AB35
First authorisation01 May 2024
Authorisation validity30 April 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Sugammadex Sandoz 200 mg/2 ml, InjektionslösungB01 May 2024
2Sugammadex Sandoz 500 mg/5 ml, InjektionslösungB01 May 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Durchstechflasche(n)V03AB3515.01.0.B
210Durchstechflasche(n)V03AB3515.01.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Sugammadex Sandoz 200 mg/2 ml authorised in Switzerland?

Yes. Sugammadex Sandoz 200 mg/2 ml is authorised by Swissmedic under authorisation number 69439, data as of 01 September 2026. The authorisation is limited until 30 April 2029.

Which dispensing category does Sugammadex Sandoz 200 mg/2 ml have?

Sugammadex Sandoz 200 mg/2 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Sugammadex Sandoz 200 mg/2 ml?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com